Enrico Cortesi

Pubblicazioni

Titolo Pubblicato in Anno
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose VACCINE 2024
Testicular ultrasonographic features predict future risk for bilateral testicular germ cell tumour: A long-term single centre follow-up study ANDROLOGY 2024
Correction to: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study (npj Breast Cancer, (2024), 10, 1, (58), 10.1038/s41523-024-00657-z) NPJ BREAST CANCER 2024
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach CANCER IMMUNOLOGY, IMMUNOTHERAPY 2023
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer FRONTIERS IN ONCOLOGY 2023
NmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives CANCER TREATMENT REVIEWS 2023
Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis ANTICANCER RESEARCH 2023
Predictive role of diffusion-weighted MRI in the assessment of response to total neoadjuvant therapy in locally advanced rectal cancer EUROPEAN RADIOLOGY 2023
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management FRONTIERS IN ONCOLOGY 2023
Oncology-Led Early Identification of Nutritional Risk: A Pragmatic, Evidence-Based Protocol (PRONTO) CANCERS 2023
Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer CELLS 2023
The management of oligometastatic disease in colorectal cancer: present strategies and future perspectives CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2023
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a Challenge BIOMEDICINES 2023
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study CANCERS 2023
Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia CANCERS 2023
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY 2023
Selective Internal Radiation Therapy (SIRT): a new emerging role for Breast Cancer Liver Metastases TUMORI 2023
Circulating CD137+ T cell subsets and MDCSs as immune biomarkers for response to anti-PD1 immunotherapy in NSCLC patients AICC INTERNATIONAL MEETING – TRANSLATIONAL AND PRECISION MEDICINE 2023
Angiogenic factors as prognostic markers in neuroendocrine neoplasms ENDOCRINE 2022
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study CANCERS 2022

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma